ROYCE & ASSOCIATES LP - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2023$6,458,079
+13.0%
437,243
-1.1%
0.07%
+20.0%
Q2 2023$5,713,960
+32.6%
442,257
+0.7%
0.06%
+27.9%
Q1 2023$4,308,415
+0.0%
439,186
+8.5%
0.04%
-4.4%
Q4 2022$4,307,561
+28.5%
404,846
+26.1%
0.04%
+18.4%
Q3 2022$3,351,000
-8.4%
321,006
+10.4%
0.04%0.0%
Q2 2022$3,659,000
+15.3%
290,650
-0.7%
0.04%
+40.7%
Q1 2022$3,174,000
-22.8%
292,833
+0.1%
0.03%
-12.9%
Q4 2021$4,114,000
-31.4%
292,400
-6.4%
0.03%
-31.1%
Q3 2021$6,001,000
+57.5%
312,400
-19.2%
0.04%
+73.1%
Q2 2021$3,810,000
+0.2%
386,8000.0%0.03%0.0%
Q1 2021$3,802,000
+120.9%
386,8000.0%0.03%
+85.7%
Q4 2020$1,721,000
+3.0%
386,8000.0%0.01%
-22.2%
Q3 2020$1,671,000
-51.3%
386,8000.0%0.02%
-52.6%
Q2 2020$3,431,000
+132.0%
386,800
-7.7%
0.04%
+90.0%
Q1 2020$1,479,000
-14.0%
418,900
+39.4%
0.02%
+33.3%
Q4 2019$1,719,000
+65.4%
300,500
+3.4%
0.02%
+50.0%
Q3 2019$1,039,000
+94.9%
290,500
+117.3%
0.01%
+100.0%
Q2 2019$533,000
-66.7%
133,700
-39.0%
0.01%
-64.3%
Q1 2019$1,602,000
-20.1%
219,1000.0%0.01%
-22.2%
Q4 2018$2,005,000
+357.8%
219,100
+97.4%
0.02%
+500.0%
Q4 2016$438,000
-65.2%
111,000
-7.5%
0.00%
-62.5%
Q3 2016$1,259,000
-47.3%
120,000
-26.8%
0.01%
-50.0%
Q2 2016$2,391,000
-58.4%
164,000
-45.2%
0.02%
-55.6%
Q1 2016$5,753,000
+13.9%
299,000
+43.1%
0.04%
+20.0%
Q4 2015$5,049,000
-35.5%
209,000
-34.5%
0.03%
-28.6%
Q3 2015$7,828,000
+44.0%
319,000
+37.5%
0.04%
+82.6%
Q2 2015$5,435,000
-6.8%
232,000
-10.8%
0.02%
+4.5%
Q1 2015$5,832,000260,0000.02%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Chicago Capital, LLC 5,791,735$85,543,9294.00%
Deep Track Capital, LP 6,756,956$99,800,2403.85%
Intrinsic Edge Capital Management LLC 1,133,099$16,735,8721.89%
Bain Capital Life Sciences Investors, LLC 915,000$13,514,5501.51%
Kynam Capital Management, LP 500,000$7,385,0001.21%
Rhenman & Partners Asset Management AB 700,000$10,339,0001.12%
AlphaCentric Advisors LLC 110,000$1,624,7000.92%
HighVista Strategies LLC 133,000$1,964,4100.91%
Affinity Asset Advisors, LLC 200,000$2,954,0000.83%
Rock Springs Capital Management LP 1,813,758$26,789,2060.72%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders